InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
2.320
+0.070 (3.11%)
Aug 14, 2025, 2:02 PM - Market open
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $2.80 million as of August 14, 2025. Its market cap has increased by 16.69% in one year.
Market Cap
2.80M
Enterprise Value
-1.16M
1-Year Change
16.69%
Ranking
Category
Stock Price
$2.32
Market Cap Chart
Since November 16, 2020, InMed Pharmaceuticals's market cap has decreased from $26.00M to $2.80M, a decrease of -89.23%. That is a compound annual growth rate of -37.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 2.70M | -20.59% |
| Dec 31, 2024 | 3.40M | 54.55% |
| Dec 29, 2023 | 2.20M | 15.79% |
| Dec 30, 2022 | 1.90M | -89.73% |
| Dec 31, 2021 | 18.50M | -19.57% |
| Dec 31, 2020 | 23.00M | -11.54% |
| Nov 16, 2020 | 26.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 576.97B |
| Johnson & Johnson | 414.43B |
| AbbVie | 350.11B |
| UnitedHealth Group | 235.48B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 226.68B |
| Novo Nordisk | 222.88B |